Global Vaginal Slings Market Size, Share, Forecast Report, 2024-2033
The global vaginal slings market size was exhibited at USD 1.90 billion in 2023 and is projected to hit around USD 2.99 billion by 2033, growing at a CAGR of 4.63% during the forecast period of 2024 to 2033.
Key Takeaways:
Vaginal Slings Market Report Scope
| Report Coverage | Details |
| Market Size in 2024 | USD 1.90 Billion |
| Market Size by 2033 | USD 2.99 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 4.63% |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Segments Covered | Product, Type, End use, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
| Key Companies Profiled | Boston Scientific Corporation; Coloplast Corp; Promedon S.A.; A.M.I. GmbH; Johnson & Johnson Services Inc.; Betatech Medical; Caldera Medical; Neomedic International; Cousin Surgery; Lotus Surgicals; UroCure. |
The market growth is attributed to factors including the growing incidence of urinary incontinence, a rising number of vaginal sling surgeries, and extensive research activities to determine the efficiency of vaginal slings over other surgeries such as vaginal mesh and colposuspension. Moreover, a keen interest of key players in the developing materially advanced products is a major factor anticipated to drive the market during the projected timeframe.
Vaginal sling is used to manage stress urinary incontinence, which is an underreported and undiagnosed medical problem. Urinary incontinence in women is caused due to changing lifestyles, early onset of menopause, pregnancy, childbirth, a rise in the obese population, an increase in the number of hysterectomy cases, urinary tract infections, and weakening of urethral sphincters and pelvic muscles. For instance, according to the Phoenix Physical Therapy, PLC., 25 million adults in the U.S. are suffering from urinary incontinence, among which 75-80% of these are women . Similarly, urinary incontinence affects nearly 38% of women in Australia. Hence, the rising incidence of urinary incontinence in women globally is expected to offer lucrative opportunities for the market over the forecast period.
Furthermore, urinary incontinence is a distressing and common complaint in elderly women. Its causes include age-related changes in the lower urinary tract, impaired neural control as well as structural changes in vesical muscle. According to a research article published on Frontiers in Public Health in December 2022, 40% of women aged 80 years and older were suffering from urinary incontinence. In addition, according to the Phoenix Physical Therapy, PLC., approximately 23% of women over 60 years deal with urinary incontinence in the U.S. Thus, the increasing geriatric population is projected to propel the market over the study period.
Moreover, operating players in the market are launching new products and receiving FDA approvals. For instance, in December 2022, Caldera Medical received FDA approval for its Desara TVez, a transvaginal sling for the treatment of stress urinary incontinence. This initiative was anticipated to boost the company’s vaginal sling offerings.
In 2022, the sudden outbreak of COVID-19 pandemic led to impositions of strict lockdowns and government regulations intended to decrease the spread of disease resulted in reduction in surgical procedures. In addition, the COVID-19 disease led many healthcare facilities to completely halt their services and cancel appointments as they were considered non-essential and high contact in nature. Surgical treatments also witnessed a setback and the number of procedures declined due to the pandemic. Thus, the COVID-19 pandemic had a negative impact on vaginal slings market.
Segments Insights:
Product Insights
Based on the product, the market is segmented into tension-free vaginal tape slings,transobturator slings, and mini-slings. The transobturator slings segment dominated the global market with a revenue share of 38.2% in 2023. The growth is attributed due the efficacy equal to tension-free vaginal tape slings, ease of procedure the minimal risk of major blood vessel injury, bowel injury, and bladder injury.
The transobturator slings procedure is minimally invasive and results in faster recovery time and shorter hospital stay. Furthermore, several key players in the market are offering advanced transobturator slings to treat urinary incontinence in women. For instance, Boston Scientific Corporation, offers Obtryx II a transobturator mid-urethral sling system with a precision blue design with boosted features. The features of the sling include improved physician visualization that aids in accurate sling placement, smooth sling placement, and intra-operative adjustability designed for minimal tissue disruption. These capabilities are driving the segment’s growth.
The mini-slings segment is expected to witness the fastest growth during the forecast period. Mini-slings are developed to decrease complications by shortening the insertion trajectory. Moreover, mini slings offer potential benefits such as the ability to perform the surgery under local anesthesia, insertion through a single vaginal incision, and shorter polypropylene tape. These slings also eliminate the need for trocar passage through the obturator foramen or external skin incisions. These advantages are expected to boost the adoption of mini-slings and drive segment growth over the forecast period.
Type Insights
Based on the type, the market is segmented into midurethral sling and traditional sling. The midurethral sling segment dominated the global market in 2023 with a revenue share of 79.7%. The growth is attributed to multiple factors, including the high durability, satisfaction rate, and no serious long-term problems associated with slings.
The midurethral slings are considered to be effective and safe in the treatment of stress urinary incontinence. For instance, midurethral slings can cure or significantly recover stress urinary incontinence in 80% to 90% of women. It is as effective as traditional sling procedures such as Burch colposuspension and pubovaginal fascial tissue slings. Furthermore, these slings are long-lasting up to 17 years, with a high satisfaction rate and no serious long-term sling-associated complications. These factors are driving the segment’s growth.
Traditional vaginal slings are re-emerging as a viable alternative to synthetic slings in light of the issues with synthetic slings. Moreover, the traditional sling procedure, such as the autologous procedure is an alternative to the use of a foreign body and has the potential to replace mid-urethral sling surgery for urinary incontinence during the forecast period.
End Use Insights
Based on the end use, the market is segmented into hospitals, clinics, and ambulatory surgical centers. The hospitals segment held the largest revenue share of 50.0% in 2023. The growth is attributed to increasing awareness of patients toward minimally invasive procedures and the rising number of traditional vaginal sling surgeries.
Furthermore, the increasing number of gynecology and urology centers is a key factor contributing to the segment growth. For instance, in May 2023, Burjeel Medical City launched an advanced gynecology institute to provide complex healthcare solutions to women of all ages. Such initiatives are boosting segment growth.
The ambulatory surgical centers (ASCs) segment is expected to have substantial growth during the forecast period. The mid-urethral procedure is an outpatient surgery. It does not require overnight hospital stay. Patients are requesting greater efficiency and affordability in healthcare. Vaginal surgeries performed in ASCs are costing up to 60% less compared to hospital outpatient department. Hence, the demand for ASCs is anticipated to increase over the fastest growth during the projected timeframe.
Regional Insights
Europe dominated the market with a revenue share of 46.0% in 2023. This can be attributed to the presence of large patient pool. The regional growth is driven by factors such as the availability of advanced healthcare facilities, the wide adoption of vaginal slings procedures, and the presence of major market players in the region.
Furthermore, a rising number of research activities, growing number of surgeons, and increasing spending of consumers are the major factors boosting the market in the region. In addition, growing adoption of modern technologies and increasing efforts for promotion are anticipated to affect the growth of the market in Europe.
The Asia Pacific region is predicted to experience significant growth in the forecast period. The growing awareness about advanced urinary incontinence management, growing healthcare expenditure, and high populations are the key factors contributing to the vaginal sling market in the region. Improving healthcare infrastructure in the region, rising healthcare expenditure, growing per capita income, and the presence of large elderly population in countries such as Japan and China are among the factors expected to further drive the market growth in the region.
Some of the prominent players in the vaginal slings market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2022 to 2033. For this study, Nova one advisor, Inc. has segmented the global vaginal slings market.
Product
Type
End Use
By Region
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers